Dopamine-receptor stimulation: Biobehavioral and biochemical consequences

Frédéric Calon; Abdallah Hadj Tahar; Pierre J. Blanchet; Marc Morissette; Richard Grondin; Martin Goulet; Jean Pierre Doucet; George S. Robertson; Eric Nestler; Thérèse Di Paolo; Paul J. Bédard

doi:10.1016/S1471-1931(00)00026-4

Dopamine-receptor stimulation: Biobehavioral and biochemical consequences

Frédéric Calon
, Abdallah Hadj Tahar
, Pierre J. Blanchet
, Marc Morissette
, Richard Grondin
, Martin Goulet
, Jean Pierre Doucet
, George S. Robertson
, Eric Nestler
, Thérèse Di Paolo
, Paul J. Bédard

Neuroscience

Producción científica: Review article › revisión exhaustiva

91 Citas (Scopus)

Resumen

The MPTP monkey is a well-characterized animal model of parkinsonism and provides an exceptional tool for the study of dyskinesias induced by dopamine-like agents. Several such agents have been tested during the past 15 years, and it has been found that the duration of action of these compounds is the most reliable variable with which to predict their dyskinesiogenic profile. It is proposed that L-dopa-induced dyskinesias represent a form of pathological learning caused by chronic pulsatile (nonphysiological) stimulation of dopamine receptors, which activates a cascade of molecular and biochemical events. These events include defective regulation of Fos proteins that belong to the ΔFosB family, increased expression of neuropeptides, and defective GABA- and glutamate-mediated neurotransmission in the output structures of the basal ganglia.

Idioma original	English
Páginas (desde-hasta)	S92-S100
Publicación	Trends in Neurosciences
Volumen	23
N.º	10 SUPPL.
DOI	https://doi.org/10.1016/S1471-1931(00)00026-4
Estado	Published - 2000

Nota bibliográfica

Funding Information:
The authors' research was supported by grants from the Medical Research Council of Canada (MRC; P.J.B. and T.D.P.) and the Parkinson Foundation of Canada (T.D.P. and P.J.B.). F.C. holds a health professional studentship from Novartis in association with the MRC of Canada and from the Fonds de la Recherche en Sant~ du Quebec.

Financiación

The authors' research was supported by grants from the Medical Research Council of Canada (MRC; P.J.B. and T.D.P.) and the Parkinson Foundation of Canada (T.D.P. and P.J.B.). F.C. holds a health professional studentship from Novartis in association with the MRC of Canada and from the Fonds de la Recherche en Sant~ du Quebec.

Financiadores
Parkinson Foundation of Canada
Medical Research Council Canada

ASJC Scopus subject areas

General Neuroscience

Acceder al documento

10.1016/S1471-1931(00)00026-4

Otros archivos y enlaces

Citar esto

@article{551545f4427d4d9690c74a2bcc14c782,

title = "Dopamine-receptor stimulation: Biobehavioral and biochemical consequences",

abstract = "The MPTP monkey is a well-characterized animal model of parkinsonism and provides an exceptional tool for the study of dyskinesias induced by dopamine-like agents. Several such agents have been tested during the past 15 years, and it has been found that the duration of action of these compounds is the most reliable variable with which to predict their dyskinesiogenic profile. It is proposed that L-dopa-induced dyskinesias represent a form of pathological learning caused by chronic pulsatile (nonphysiological) stimulation of dopamine receptors, which activates a cascade of molecular and biochemical events. These events include defective regulation of Fos proteins that belong to the ΔFosB family, increased expression of neuropeptides, and defective GABA- and glutamate-mediated neurotransmission in the output structures of the basal ganglia.",

author = "Fr{\'e}d{\'e}ric Calon and Tahar, \{Abdallah Hadj\} and Blanchet, \{Pierre J.\} and Marc Morissette and Richard Grondin and Martin Goulet and Doucet, \{Jean Pierre\} and Robertson, \{George S.\} and Eric Nestler and \{Di Paolo\}, Th{\'e}r{\`e}se and B{\'e}dard, \{Paul J.\}",

note = "Funding Information: The authors' research was supported by grants from the Medical Research Council of Canada (MRC; P.J.B. and T.D.P.) and the Parkinson Foundation of Canada (T.D.P. and P.J.B.). F.C. holds a health professional studentship from Novartis in association with the MRC of Canada and from the Fonds de la Recherche en Sant\textasciitilde{} du Quebec.",

year = "2000",

doi = "10.1016/S1471-1931(00)00026-4",

language = "English",

volume = "23",

pages = "S92--S100",

number = "10 SUPPL.",

}

TY - JOUR

T1 - Dopamine-receptor stimulation

T2 - Biobehavioral and biochemical consequences

AU - Calon, Frédéric

AU - Tahar, Abdallah Hadj

AU - Blanchet, Pierre J.

AU - Morissette, Marc

AU - Grondin, Richard

AU - Goulet, Martin

AU - Doucet, Jean Pierre

AU - Robertson, George S.

AU - Nestler, Eric

AU - Di Paolo, Thérèse

AU - Bédard, Paul J.

N1 - Funding Information: The authors' research was supported by grants from the Medical Research Council of Canada (MRC; P.J.B. and T.D.P.) and the Parkinson Foundation of Canada (T.D.P. and P.J.B.). F.C. holds a health professional studentship from Novartis in association with the MRC of Canada and from the Fonds de la Recherche en Sant~ du Quebec.

PY - 2000

Y1 - 2000

N2 - The MPTP monkey is a well-characterized animal model of parkinsonism and provides an exceptional tool for the study of dyskinesias induced by dopamine-like agents. Several such agents have been tested during the past 15 years, and it has been found that the duration of action of these compounds is the most reliable variable with which to predict their dyskinesiogenic profile. It is proposed that L-dopa-induced dyskinesias represent a form of pathological learning caused by chronic pulsatile (nonphysiological) stimulation of dopamine receptors, which activates a cascade of molecular and biochemical events. These events include defective regulation of Fos proteins that belong to the ΔFosB family, increased expression of neuropeptides, and defective GABA- and glutamate-mediated neurotransmission in the output structures of the basal ganglia.

AB - The MPTP monkey is a well-characterized animal model of parkinsonism and provides an exceptional tool for the study of dyskinesias induced by dopamine-like agents. Several such agents have been tested during the past 15 years, and it has been found that the duration of action of these compounds is the most reliable variable with which to predict their dyskinesiogenic profile. It is proposed that L-dopa-induced dyskinesias represent a form of pathological learning caused by chronic pulsatile (nonphysiological) stimulation of dopamine receptors, which activates a cascade of molecular and biochemical events. These events include defective regulation of Fos proteins that belong to the ΔFosB family, increased expression of neuropeptides, and defective GABA- and glutamate-mediated neurotransmission in the output structures of the basal ganglia.

UR - https://www.scopus.com/pages/publications/10644250114

UR - https://www.scopus.com/pages/publications/10644250114#tab=citedBy

U2 - 10.1016/S1471-1931(00)00026-4

DO - 10.1016/S1471-1931(00)00026-4

M3 - Review article

C2 - 11052226

AN - SCOPUS:10644250114

SN - 0166-2236

VL - 23

SP - S92-S100

JO - Trends in Neurosciences

JF - Trends in Neurosciences

IS - 10 SUPPL.

ER -

Dopamine-receptor stimulation: Biobehavioral and biochemical consequences

Resumen

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto